Malignant versus benign vertebral collapse: are new imaging techniques useful?

Cancer Imaging. 2009 Oct 2;9 Spec No A(Special issue A):S49-51. doi: 10.1102/1470-7330.2009.9013.

Abstract

Benign and malignant vertebral collapse is common in the middle-aged and elderly population. Differential diagnosis sometimes remains difficult using radiographs, computed tomography (CT) and magnetic resonance imaging (MRI) if strong edema is present. Established morphological criteria and new methods such as positron emission tomography (PET)-CT and diffusion and perfusion MRI are helpful for the correct diagnosis. Increased fluorodeoxyglucose (FDG) uptake accounts for the neoplastic cause of a fracture. Hyperintensity on diffusion-weighted images and a high plasma flow also are associated with the malignant cause of a fracture. However, the combination of all criteria should be taken into account for differential diagnosis.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Diffusion Magnetic Resonance Imaging / methods*
  • Fluorine Radioisotopes
  • Fluorodeoxyglucose F18
  • Fractures, Compression / diagnosis
  • Fractures, Compression / diagnostic imaging
  • Fractures, Compression / etiology*
  • Fractures, Compression / pathology
  • Fractures, Spontaneous / diagnosis
  • Fractures, Spontaneous / diagnostic imaging
  • Fractures, Spontaneous / etiology*
  • Fractures, Spontaneous / pathology
  • Humans
  • Osteoporosis / complications
  • Osteoporosis / diagnosis
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Spinal Fractures / diagnosis
  • Spinal Fractures / diagnostic imaging
  • Spinal Fractures / etiology*
  • Spinal Fractures / pathology
  • Spinal Neoplasms / complications
  • Spinal Neoplasms / diagnosis*
  • Spinal Neoplasms / diagnostic imaging
  • Spinal Neoplasms / pathology
  • Spinal Neoplasms / secondary
  • Spondylitis / complications
  • Spondylitis / diagnosis
  • Tomography, X-Ray Computed

Substances

  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18